Reported Jul 19, 2017 · Terminated
BRILINTA (ticagrelor) tablets, 90 mg, 8-count Professional Sample bottles, Rx only, Mfd. for: AstraZeneca…
AstraZeneca Pharmaceuticals, LP
High riskUsing this product could cause serious injury, illness or death — stop using it now.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: AstraZeneca Pharmaceuticals, LP · 587 Old Baltimore Pike · Newark, DE · 19702-1307
Is this the product you have?
- BRILINTA (ticagrelor) tablets, 90 mg, 8-count Professional Sample bottles, Rx only, Mfd
- forAstraZeneca Pharmaceuticals LP, Wilmington, DE 19850
- ByAstraZeneca AB, SE-151 85 Sodertalje, Sweden, NDC 0186-0777-08
- Lot codes and dates
Lot # JB5047Exp 10/19
- Amount recalled
- 40,368 bottles
Where it was sold
- Nationwide
- PR
Why it was recalled
Stop using this product now
Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the expected 8 BRILINTA tablets.
Using this product could cause serious injury, illness or death — stop using it now.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new AstraZeneca Pharmaceuticals, LP recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.